Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial.

Alonso-Vega C, Pinto Rocha JJ, Rojas Delgadillo LG, García Ruiloba W, Palacios López A, Pinto Rocha LV, Méndez Bartolomé S, González VR, Laserna M, Ribeiro I, Pinazo MJ, Thomas MC, López MC, Losada Galván I, Ortiz L, Schijman AG, Urbina JA, Sanz Bravo S, Gascón J, Torrico F, Almeida IC, TESEO Study Group

Open source

DOI: 10.1016/s1473-3099(26)00436-6
Published: 2026 Sep 22
Container: The Lancet. Infectious diseases
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-26-00436-6,
  title = {Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial.},
  author = {Alonso-Vega C and Pinto Rocha JJ and Rojas Delgadillo LG and García Ruiloba W and Palacios López A and Pinto Rocha LV and Méndez Bartolomé S and González VR and Laserna M and Ribeiro I and Pinazo MJ and Thomas MC and López MC and Losada Galván I and Ortiz L and Schijman AG and Urbina JA and Sanz Bravo S and Gascón J and Torrico F and Almeida IC and TESEO Study Group},
  year = {2026},
  journal = {The Lancet. Infectious diseases},
  doi = {10.1016/s1473-3099(26)00436-6},
  url = {https://doi.org/10.1016/s1473-3099(26)00436-6}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial.
AU  - Alonso-Vega C
AU  - Pinto Rocha JJ
AU  - Rojas Delgadillo LG
AU  - García Ruiloba W
AU  - Palacios López A
AU  - Pinto Rocha LV
AU  - Méndez Bartolomé S
AU  - González VR
AU  - Laserna M
AU  - Ribeiro I
AU  - Pinazo MJ
AU  - Thomas MC
AU  - López MC
AU  - Losada Galván I
AU  - Ortiz L
AU  - Schijman AG
AU  - Urbina JA
AU  - Sanz Bravo S
AU  - Gascón J
AU  - Torrico F
AU  - Almeida IC
AU  - TESEO Study Group
PY  - 2026
JO  - The Lancet. Infectious diseases
DO  - 10.1016/s1473-3099(26)00436-6
UR  - https://doi.org/10.1016/s1473-3099(26)00436-6
ER  -

APA

C, A., JJ, P. R., LG, R. D., W, G. R., A, P. L., LV, P. R., S, M. B., VR, G., M, L., I, R., MJ, P., MC, T., MC, L., I, L. G., L, O., AG, S., JA, U., S, S. B., J, G., F, T., IC, A., & Group, T. S. (2026). Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial.. The Lancet. Infectious diseases. https://doi.org/10.1016/s1473-3099(26)00436-6

Source records

pubmed · retrieved 2026-09-26T01:04:42.326Z
europe-pmc · retrieved 2026-09-26T01:04:42.335Z